1. COVID-19 Vaccination Rates in a Global HIV Cohort.
- Author
-
Fulda, Evelynne S, Fitch, Kathleen V, Overton, Edgar T, Zanni, Markella V, Aberg, Judith A, Currier, Judith S, Lu, Michael T, Malvestutto, Carlos, Fichtenbaum, Carl J, Martinez, Esteban, Umbleja, Triin, Douglas, Pamela S, Ribaudo, Heather J, and Grinspoon, Steven K
- Subjects
COVID-19 vaccines ,COVID-19 ,CLINICAL trial registries ,CORONAVIRUS diseases ,GLOBAL burden of disease ,COVID-19 pandemic - Abstract
Little is known regarding coronavirus disease 2019 (COVID-19) vaccination rates in people with HIV (PWH), a vulnerable population with significant morbidity from COVID-19. We assessed COVID-19 vaccination rates among 6952 PWH in the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) compared to region- and country-specific vaccination data. The global probability of COVID-19 vaccination through end of July 2021 was 55% among REPRIEVE participants with rates varying substantially by Global Burden of Disease (GBD) superregion. Among PWH, factors associated with COVID-19 vaccination included residence in high-income regions, age, white race, male sex, body mass index, and higher cardiovascular risk. Clinical Trials Registration. NCT02344290. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF